Pharma Journalist -

GlaxoSmithKline plc (GSK) announced that the US Food and Drug Administration (FDA) has granted a priority review for the company’s application seeking approval of Nucala (mepolizumab)…
Read More...

Bristol Myers Squibb announced that the European Commission (EC) has approved Zeposia (ozanimod) for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS)…
Read More...

Novavax, Inc. announced the acquisition of Praha Vaccines a.s., part of the Cyrus Poonawalla Group, in an all cash transaction of approximately $167 million. The acquisition includes a…
Read More...

Rentschler Biopharma SE announced that the company has entered into a strategic collaboration with Genmab for the process development and manufacture of bispecific antibodies generated…
Read More...

Gilead Sciences, Inc. and Arcus Biosciences, Inc. announced that the companies have entered into a 10-year partnership to co-develop and co-commercialize current and future therapeutic…
Read More...

PhaseBio Pharmaceuticals, Inc. announced FDA authorization to proceed with VANGARD, a potentially pivotal clinical trial to evaluate PB1046 as a treatment for hospitalized COVID-19…
Read More...

AbCellera announced that it has closed a US$105 million Series B financing. The financing was led by OrbiMed and current investor DCVC Bio, with an investor syndicate that includes…
Read More...

EdiGene, Inc., which develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of diseases, and Immunochina, a company dedicated…
Read More...

SMi reports: Envisagenics will be presenting latest case study on RNA-therapeutics for Triple Negative Breast Cancer Envisagenics is a spin out of the world-renowned Cold Spring…
Read More...

Thermo Fisher Scientific, the world leader in serving science, and Biognosys, a leading developer of next-generation proteomics solutions, announce they are continuing their…
Read More...